The percentage of OLFM4- and SHH-positive prostate-cancer specimens was 80% and 40% in Gleason scores 4–7, and 22% and 57% in Gleason scores 8–10, respectively (Fig. 7c). This evidence concerns the gene OLFM4 and Familial prostate cancer.